Published in Cancer Weekly, August 3rd, 2004
The treatment was developed by researchers at The Johns Hopkins Kimmel Cancer Center. OncoMethylome Sciences is the exclusive licensee of this patent, as well as of other key patents in the field of gene methylation technology.
Alkylating agents are used for the treatment of various cancers including tumors of the brain, nervous system and lymph system. Their function is to damage tumor-cell DNA resulting in cell death. However, cells are normally protected by enzymes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.